Tikun Olam-Cannbit Pharmaceuticals Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Tikun Olam-Cannbit Pharmaceuticals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 16.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Tikun Olam-Cannbit Pharmaceuticals Ltd's (TLV:TKUN) Popularity With Investors Under Threat As Stock Sinks 26%
Dec 02
Health Check: How Prudently Does Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Use Debt?
Oct 23Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?
Jun 21Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 28Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Jul 21Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?
Oct 03Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?
Jun 03Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt
Oct 17Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?
May 19Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return
Mar 19How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 02
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tikun Olam-Cannbit Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 43 | -50 | 4 | 4 | N/A |
| 3/31/2024 | 43 | -69 | 0 | 1 | N/A |
| 12/31/2023 | 44 | -89 | -4 | -3 | N/A |
| 9/30/2023 | 47 | -98 | -15 | -13 | N/A |
| 6/30/2023 | 51 | -107 | -26 | -23 | N/A |
| 3/31/2023 | 50 | -77 | -28 | -21 | N/A |
| 12/31/2022 | 49 | -48 | -30 | -18 | N/A |
| 9/30/2022 | 45 | -38 | -28 | -15 | N/A |
| 6/30/2022 | 41 | -27 | -26 | -12 | N/A |
| 3/31/2022 | 39 | -30 | -30 | -18 | N/A |
| 12/31/2021 | 37 | -33 | -33 | -23 | N/A |
| 9/30/2021 | 32 | -34 | -40 | -26 | N/A |
| 6/30/2021 | 28 | -35 | -47 | -30 | N/A |
| 3/31/2021 | 25 | -34 | -49 | -27 | N/A |
| 12/31/2020 | 22 | -33 | -51 | -24 | N/A |
| 9/30/2020 | 16 | -27 | -42 | -18 | N/A |
| 6/30/2020 | 11 | -20 | -33 | -11 | N/A |
| 3/31/2020 | 5 | -16 | -25 | -7 | N/A |
| 12/31/2019 | N/A | -11 | -16 | -3 | N/A |
| 9/30/2019 | N/A | -17 | -14 | -3 | N/A |
| 6/30/2019 | N/A | -24 | -11 | -3 | N/A |
| 3/31/2019 | N/A | -23 | -7 | -2 | N/A |
| 12/31/2018 | N/A | -21 | -3 | -2 | N/A |
| 12/31/2017 | N/A | 0 | N/A | 0 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -1 | N/A |
| 12/31/2015 | N/A | -3 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if TKUN's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if TKUN's earnings are forecast to grow faster than the IL market
High Growth Earnings: Insufficient data to determine if TKUN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if TKUN's revenue is forecast to grow faster than the IL market.
High Growth Revenue: Insufficient data to determine if TKUN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TKUN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 08:24 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tikun Olam-Cannbit Pharmaceuticals Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.